Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.37 USD | +2.04% | -13.79% | -93.09% |
05-07 | Jefferies Downgrades Lyra Therapeutics to Hold, Price Target at $0.50 | MT |
05-07 | HC Wainwright Downgrades Lyra Therapeutics to Neutral From Buy | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-93.09% | 22.11M | |
+27.96% | 48.16B | |
-0.76% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.94% | 25.59B | |
-22.74% | 18.96B | |
+8.11% | 12.92B | |
+30.11% | 12.03B | |
-2.20% | 11.77B |
- Stock Market
- Equities
- LYRA Stock
- News Lyra Therapeutics, Inc.
- Transcript : Lyra Therapeutics, Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-10-2023 04